224 related articles for article (PubMed ID: 22322951)
1. Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer.
Viehl CT; Guller U; Cecini R; Langer I; Ochsner A; Terracciano L; Riehle HM; Laffer U; Oertli D; Zuber M
Ann Surg Oncol; 2012 Jun; 19(6):1959-65. PubMed ID: 22322951
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT
Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.
Stojadinovic A; Nissan A; Protic M; Adair CF; Prus D; Usaj S; Howard RS; Radovanovic D; Breberina M; Shriver CD; Grinbaum R; Nelson JM; Brown TA; Freund HR; Potter JF; Peretz T; Peoples GE
Ann Surg; 2007 Jun; 245(6):846-57. PubMed ID: 17522508
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo sentinel lymph node mapping in laparoscopic resection of colon cancer.
Rivet EB; Mutch MG; Ritter JH; Khan AA; Lewis JS; Winslow E; Fleshman JW
Colorectal Dis; 2011 Nov; 13(11):1249-55. PubMed ID: 21083799
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.
Lim SJ; Feig BW; Wang H; Hunt KK; Rodriguez-Bigas MA; Skibber JM; Ellis V; Cleary K; Chang GJ
Ann Surg Oncol; 2008 Jan; 15(1):46-51. PubMed ID: 17985187
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of sentinel lymph node biopsy for staging, treatment and prognosis of colon and gastric cancer.
Dragan R; Nebojsa M; Dejan S; Ivan P; Dragos S; Damir J; Predrag S; Vladan Z
Hepatogastroenterology; 2009; 56(96):1606-11. PubMed ID: 20214202
[TBL] [Abstract][Full Text] [Related]
7. Use of sentinel node mapping for cancer of the colon: 'to map or not to map".
Thomas KA; Lechner J; Shen P; Waters GS; Geisinger KR; Levine EA
Am Surg; 2006 Jul; 72(7):606-11; discussion 611-2. PubMed ID: 16875082
[TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node mapping in colon cancer: current status.
de Haas RJ; Wicherts DA; Hobbelink MG; Borel Rinkes IH; Schipper ME; van der Zee JA; van Hillegersberg R
Ann Surg Oncol; 2007 Mar; 14(3):1070-80. PubMed ID: 17206482
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping for carcinoma of the colon: a pilot study.
Waters GS; Geisinger KR; Garske DD; Loggie BW; Levine EA
Am Surg; 2000 Oct; 66(10):943-5; discussion 945-6. PubMed ID: 11261621
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
13. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Bilchik AJ; DiNome M; Saha S; Turner RR; Wiese D; McCarter M; Hoon DS; Morton DL
Arch Surg; 2006 Jun; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
[TBL] [Abstract][Full Text] [Related]
14. [An initial experience of the use of sentinel lymph node biopsy in squamous cell cancer of the vulva].
Li B; Wu LY; Liu L; Zhang R; Zhang GY; Yu GZ
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):364-8. PubMed ID: 19573313
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer.
Viehl CT; Guller U; Langer I; Laffer U; Oertli D; Zuber M
World J Surg; 2013 Apr; 37(4):873-7. PubMed ID: 23354923
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer.
Martínez-Palones JM; Pérez-Benavente MA; Gil-Moreno A; Díaz-Feijoo B; Roca I; García-Jiménez A; Aguilar-Martínez I; Xercavins J
Gynecol Oncol; 2006 Dec; 103(3):865-70. PubMed ID: 16828149
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node staging in colon carcinoma: value of sentinel lymph node biopsy with radiocolloid and blue staining.
Terwisscha Van Scheltinga SE; Den Boer FC; Pijpers R; Meyer GA; Engel AF; Silvis R; Meijer S; van der Sijp JR
Scand J Gastroenterol Suppl; 2006; (243):153-7. PubMed ID: 16782635
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma.
Ji YB; Lee KJ; Park YS; Hong SM; Paik SS; Tae K
Ann Surg Oncol; 2012 Jun; 19(6):1868-73. PubMed ID: 21989668
[TBL] [Abstract][Full Text] [Related]
20. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
